UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000043430 |
|---|---|
| Receipt number | R000049589 |
| Scientific Title | Prevalence and clinical course of pulmonary manifestations in patients with chronic liver disease |
| Date of disclosure of the study information | 2021/05/01 |
| Last modified on | 2024/02/28 07:12:38 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Prevalence and clinical course of pulmonary manifestations in patients with chronic liver disease
Acronym
Prevalence and clinical course of pulmonary manifestations in patients with chronic liver disease
Scientific Title
Prevalence and clinical course of pulmonary manifestations in patients with chronic liver disease
Scientific Title:Acronym
Prevalence and clinical course of pulmonary manifestations in patients with chronic liver disease
Region
| Japan |
Condition
Condition
chronic liver disease
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluation of prevalence of pulmonary manifestations
Basic objectives2
Others
Basic objectives -Others
Prevalence
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Prevalence of pulmonary manifestations
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Patients with chronic liver disease
Key exclusion criteria
Patients under 18 years old
Target sample size
400
Research contact person
Name of lead principal investigator
| 1st name | Masatoshi |
| Middle name | |
| Last name | Ishigami |
Organization
Nagoya University
Division name
Gastroenterology and Hepatology
Zip code
466-8550
Address
tsuruma-cho, showa-ku, nagoya city
TEL
0527442169
masaishi@med.nagoya-u.ac.jp
Public contact
Name of contact person
| 1st name | Yoji |
| Middle name | |
| Last name | Ishizu |
Organization
Nagoya University
Division name
Gastroenterology and Hepatology
Zip code
466-8550
Address
tsuruma-cho, showa-ku, nagoya city
TEL
0527442169
Homepage URL
y-ishizu@med.nagoya-u.ac.jp
Sponsor or person
Institute
Nagoya University
Institute
Department
Personal name
Funding Source
Organization
Nagoya University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Nagoya ethic commettee
Address
tsuruma-cho, showa-ku, nagoya city
Tel
0527448550
ethics@med.nagoya-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 05 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
150
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2021 | Year | 02 | Month | 24 | Day |
Date of IRB
| 2021 | Year | 03 | Month | 31 | Day |
Anticipated trial start date
| 2021 | Year | 05 | Month | 01 | Day |
Last follow-up date
| 2027 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Evaluation for the prevalence of pulmonary complications in patients with chronic liver disease
Management information
Registered date
| 2021 | Year | 02 | Month | 24 | Day |
Last modified on
| 2024 | Year | 02 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049589
